诺诚健华(09969.HK)11月13日举行董事会会议考虑及批准第三季度业绩

Core Viewpoint - The company, Innovent Biologics (09969.HK), has announced that it will hold a board meeting on November 13, 2025, to consider and approve its unaudited third-quarter results for the nine months ending September 30, 2025 [1] Summary by Category - Company Announcement - Innovent Biologics will conduct a board meeting on November 13, 2025, to review and approve its financial results [1] - The meeting will focus on the unaudited third-quarter performance for the period ending September 30, 2025 [1]